US 8030307
Bicyclic, C5-substituted proline derivatives as inhibitors of the hepatitis C virus NS3 protease
granted A61KA61K38/00A61P
Quick answer
US patent 8030307 (Bicyclic, C5-substituted proline derivatives as inhibitors of the hepatitis C virus NS3 protease) held by Enanta Pharmaceuticals, Inc. expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K38/00, A61P, A61P31/12